Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Jasper Therapeutics, Inc. - Class A Common Stock
(NQ:
JSPR
)
1.840
+0.095 (+5.44%)
Streaming Delayed Price
Updated: 1:00 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Jasper Therapeutics, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
Next >
CoreWeave Bulls Should Brace For 'Wild, Lumpy, Volatile Ride,' JPMorgan Says
↗
November 11, 2025
JPMorgan downgrades CoreWeave, citing turbulence in AI infrastructure market. Despite near-term challenges, long-term growth...
Via
Benzinga
Topics
Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
September 24, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
September 19, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
September 18, 2025
Via
Benzinga
JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q4 2023
↗
March 06, 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Via
InvestorPlace
Stay updated with the stocks that are on the move in today's after-hours session.
↗
September 18, 2025
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via
Chartmill
Jasper Reports Wider Loss in Fiscal Q2
↗
August 13, 2025
Via
The Motley Fool
Jasper Therapeutics Gets Hit With Downgrades Over Faulty Batch Of Skin Allergy Drug; Retail Sees ‘Overreaction’
↗
July 08, 2025
The company flagged that 10 of 13 patients in two dosing cohorts received a compromised batch of briquilimab, leading to muted results.
Via
Stocktwits
Top stock movements in today's session.
↗
July 07, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Jasper Therapeutics Shares Fall On Briquilimab Drug Lot Problem
↗
July 07, 2025
Jasper shares drop after updated BEACON study shows strong results but faces disruption from compromised drug product lot and halted pipeline programs.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
July 07, 2025
Via
Benzinga
Dow Dips 1%; Mustang Bio Shares Spike Higher
↗
July 07, 2025
Via
Benzinga
Topics
Stocks
Here are the top movers in Monday's session.
↗
July 07, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
July 07, 2025
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
Nasdaq Falls Over 100 Points; Capgemini To Acquire WNS
↗
July 07, 2025
Via
Benzinga
What's going on in today's pre-market session
↗
July 07, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 07, 2025
Via
Benzinga
Russell 2000 Index Forecast As The Crash Continues: Buy The Dip?
↗
April 22, 2025
The Russell 2000 Index has plunged and formed a death cross this year as American stocks sink amid rising worries about Donald Trump’s policies.
Via
Talk Markets
Topics
Government
Stocks / Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
January 08, 2025
Via
Benzinga
Crude Oil Down 1%; US Weekly Jobless Claims Decline
↗
January 08, 2025
Via
Benzinga
Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors
↗
January 08, 2025
Jasper Therapeutics reports strong briquilimab efficacy in CSU with UAS7 reductions, dose-dependent responses, and Phase 2b plans by late 2025.
Via
Benzinga
US Stocks Down; Acuity Brands Posts Weak Revenue
↗
January 08, 2025
Via
Benzinga
Futures Slump As Yields, Dollar Soar
↗
January 08, 2025
In premarket trading Quantum stocks tumbled after Nvidia CEO Jensen Huang said that “very useful” quantum computers are likely decades away.
Via
Talk Markets
Topics
Commodities
Stocks / Equities
Why Is Chronic Disease-Focused Jasper Therapeutics Stock Trading Higher On Monday?
↗
October 14, 2024
Jasper Therapeutics' SPOTLIGHT study reports 93% clinical response in cold urticaria and symptomatic dermographism. The 120mg dose showed 83% complete response and no severe adverse events. Full data...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
October 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
October 09, 2024
Via
Benzinga
JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q2 2024
↗
August 13, 2024
JSPR stock results show that Jasper Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
June 20, 2024
Via
Benzinga
JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q1 2024
↗
May 14, 2024
JSPR stock results show that Jasper Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
↗
May 06, 2024
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
